FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 357:531-533 August 9, 2007 Number 6 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

"Old wine in a new bottle." "A financial gamble." "An early glimpse of the next generation of pay for performance." All these appraisals have been applied to Geisinger Health System's new approach to elective coronary-artery bypass grafting (CABG), which has been described with words rarely invoked in health care, such as "promise" and "guarantee." Geisinger, an integrated health care delivery system in northeastern Pennsylvania, promises that 40 key processes will be completed for every patient who undergoes elective CABG — even though several of the "benchmarks" are to be reached before or after hospitalization. And although Geisinger cannot guarantee good . . . [Full Text of this Article]

Source Information

Dr. Lee is network president at Partners Healthcare System, Boston, and an associate editor of the Journal. He is a member of the Geisinger board of directors.

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.